The over-accumulation of fat in NASH (non-alcoholic steatohepatitis) leads to the activation of the PPAR signaling pathway, and the over-activation of this signaling pathway also causes liver lesions. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.